NFKB1 and breast cancer: developed an αvβ3 receptor‐targeted TET‐CSOSA/CEL micelle that effectively blocked the NF‐κB signaling pathway, leading to a substantial reduction in lung metastasis and situ tumor growth in breast cancer.